AstraZeneca rejects Pfizer's 'final' $117bn bid | Bangkok Post: news

News > World

AstraZeneca rejects Pfizer's 'final' $117bn bid

- +

British drugmaker AstraZeneca on Monday rejected a "final" $117-billion takeover bid from US rival Pfizer, appearing to put an end to a deal that would have created a sector giant. 

British drugs giant AstraZeneca has rejected a final takeover bid from US rival Pfizer worth $117 billion

Pfizer lodged a fourth and final offer worth 85 billion euros or pound sterling69 billion on Sunday, pitched at pound sterling55 per share, and said it would not proceed without a recommendation from management.

This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.

0 people commented about the above

Readers are urged not to submit comments that may cause legal dispute including slanderous, vulgar or violent language, incorrectly spelt names, discuss moderation action, quotes with no source or anything deemed critical of the monarchy. More information in our terms of use.

Please use our forum for more candid, lengthy, conversational and open discussion between one another.

  • Latest
  • Oldest
  • Most replied to
  • Most liked
  • Most disliked

    Click here to view more comments